tailieunhanh - Báo cáo y học: "Two-year Outcome of Turkish Patients Treated with Zotarolimus Versus Paclitaxel Eluting Stents in an Unselected Population with Coronary Artery Disease in the Real World: A Prospective Non-randomized Registry in Southern Turkey"

Tuyển tập các báo cáo nghiên cứu khoa học ngành y học tạp chí Medical Sciences dành cho các bạn sinh viên ngành y tham khảo đề tài: Two-year Outcome of Turkish Patients Treated with Zotarolimus Versus Paclitaxel Eluting Stents in an Unselected Population with Coronary Artery Disease in the Real World: A Prospective Non-randomized Registry in Southern Turkey. | Int. J. Med. Sci. 2011 8 68 International Journal of Medical Sciences 2011 8 1 68-73 Ivyspring International Publisher. All rights reserved. Research Paper Two-year Outcome of Turkish Patients Treated with Zotarolimus Versus Paclitaxel Eluting Stents in an Unselected Population with Coronary Artery Disease in the Real World A Prospective Non-randomized Registry in Southern Turkey Davran Ọiọek1- Hasan Pekdemir2 Cevahir Haberal1 Nihat Kalay3 Suleyman Binici4 Hakan Altay4 Haldun Muderrisoglu5 1. Baậkent University School of Medicine Department of Cardiology Antalya 2. Inonu University School of Medicine Department of Cardiology Malatya 3. Erciyes University School of Medicine Department of Cardiology Kayseri 4. Baậkent University School of Medicine Department of Cardiology Adana 5. Baậkent University School of Medicine Department of Cardiology Ankara. H Corresponding author Dr. Davran Cicek Baậkent University School of Medicine Department of Cardiology Alanya Antalya Turkey. Tel 90 532 3336466 Fax 902425115563. E-mail davrancicek@ Received Accepted Published Abstract Background Our purpose was to investigate the clinical outcomes of Zotarolimus- and Paclitaxel-eluting stents in Turkish patients with coronary artery disease CAD . In general the outcome of drug-eluting stent DES placement has a proven efficacy in randomized trials. However the difference in efficacy between the Zotarolimus and Paclitaxel-eluting stents in unselected Turkish patients is controversial. Therefore we investigated the clinical outcomes of these two drug-eluting stents in the real-world. Methods We created a registry and prospectively analyzed data on a consecutive series of all patients who presented to our institution with symptomatic coronary artery disease between February 2005 and March 2007 and who were treated with the zotarolimus- or the paclitaxel-eluting stent. The follow-up period was approximately two years. The primary end-point was major

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN
crossorigin="anonymous">
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.